Keywords: هموفیلی B; aFVII; activated FVII; AHA; acquired hemophilia A; anti-hFVIII; anti-human FVIII; aPCC; activated prothrombin complex concentrate; aPTT; activated partial thromboplastin time; AT; antithrombin; AUC; area under the curve; BPA; bypassing agent; BU; Bethesda
مقالات ISI هموفیلی B (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: هموفیلی B; Hemophilia B; Hemarthrosis; Ankle joint; Hemofilia B; Hemartrose; Articulação do tornozelo;
Keywords: هموفیلی B; Hemofilia B; Hemartrose; Articulação do tornozelo; Hemophilia B; Hemarthrosis; Ankle joint;
Keywords: هموفیلی B; Hemofilia B; Hemofilia A; Dolor; Analgésicos opioides; Dolor agudo; Hemophilia B; Hemophilia A; Pain; Analgesics, opioid; Acute pain;
Keywords: هموفیلی B; Hemophilia B; Hemophilia A; Pain; Analgesics opioid; Acute pain; Hemofilia B; Hemofilia A; Dolor; Analgésicos opioides; Dolor agudo;
Keywords: هموفیلی B; Hemophilia A; Hemophilia B; Bleeding; Mutations; Thrombophilia;
Keywords: هموفیلی B; aPCC; activated prothrombin complex concentrate; aPL; antiphospholipid; FIX; factor IX; FMD; flow-mediated dilatation; FV; factor V; FVIII; factor VIII; HA; hemophilia A; HB; hemophilia B; HIV; human immunodeficiency virus; IMT; intima-media thickness; MT
Keywords: هموفیلی B; Gene therapy; Hemophilia A; Hemophilia B; Adeno-associated virus; Clinical trial;
Keywords: هموفیلی B; Gene therapy; Inherited monogenic disorders; SCID; Hemophilia B; Lipoprotein lipase; Deficiency
Keywords: هموفیلی B; Hemophilia B; PROLONG-9FP; rIX-FP; Recombinant factor IX; On-demand; ProphylaxisAEs, adverse events; AsBR, annualized spontaneous bleeding rate; FIX, factor IX; IV, intravenous; pdFIX, plasma-derived factor IX; PK, pharmacokinetics; rFIX, recombinant fact
Keywords: هموفیلی B; Hemophilia A; Hemophilia B; Inhibitors; NovoSeven®; rVIIa-FP; PROLONG-7FPFEIBA®, Factor Eight Bypassing Activity; FIX, factor IX; FVII, factor VII; FVII:Ag, factor VII antigen; FVIIa, activated factor VII; FVIII, factor VIII; INR, international normalized
Keywords: هموفیلی B; Gene therapy; Hemophilia B; Human factor IX; Bone-marrow mesenchymal stem cells; Hematopoietic lineage; Cell-based therapy
Application of the ISTH bleeding score in hemophilia
Keywords: هموفیلی B; Hemophilia A; Hemophilia B; ISTH; Bleeding assessment tool; Inherited bleeding disorders;
Risques en dermatologie interventionnelle chez les patients hémophiles ou atteints de la maladie de Willebrand
Keywords: هموفیلی B; Hémophilie A; Hémophilie B; Maladie de Willebrand; Chirurgie dermatologique; Risque hémorragique; Hemophilia A; Hemophilia B; Von Willebrand disease; Dermatologic surgery; Bleeding complications;
Usual and unusual mutations in a cohort of Belgian patients with hemophilia B
Keywords: هموفیلی B; Hemophilia B Brandenburg; Hemophilia B; F9 gene; Promoter; Alu sequences;
Noninvasive prenatal diagnosis for X-linked disease by maternal plasma sequencing in a family of Hemophilia B
Keywords: هموفیلی B; Massively parallel sequencing; Hemophilia B; Noninvasive prenatal diagnosis; Single-gene disorders; Target-gene capture;
Identification of a novel mutation in HPS6 in a patient with hemophilia B and oculocutaneous albinism
Keywords: هموفیلی B; Hermansky-Pudlak syndrome; Platelet storage pool disorder; Oculocutaneous albinism; Christmas disease; Hemophilia B; Factor IX deficiency;
Human cell lines: A promising alternative for recombinant FIX production
Keywords: هموفیلی B; Hemophilia B; Coagulation factor IX; Human cell lines; Gamma-carboxylation; Lentiviral vectorEGFP, enhanced green fluorescent protein; MOI, multiplicity of infection; μmax, maximum specific cell growth rate; td, doubling time; EDTA, ethylenediaminetetraac
Pharmacokinetics, Efficacy, and Safety of Nonacog Alfa in Previously Treated Patients with Moderately Severe to Severe Hemophilia B
Keywords: هموفیلی B; BeneFIX; factor IX; hemophilia B; nonacog alfa; pharmacokinetics;
Heparin supplement counteracts the prohemostatic effect of prothrombin complex concentrate and factor IX concentrate: An in vitro evaluation
Keywords: هموفیلی B; Oral anticoagulants; Hemophilia B; Rivaroxaban; Vitamin K-dependent factors; Blood products
Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing
Keywords: هموفیلی B; Carrier screening; prenatal screening; autosomal recessive disorder; autosomal dominant disorder; X-linked disorder; thalassemia; hemoglobinopathy; cystic fibrosis; Duchenne/Becker muscular dystrophy; Fragile X; spinal muscular atrophy; Tay-Sachs disease;
Opinion commune de la SOGC et du CCGM sur le dépistage génétique en contexte de procréation : Mise à jour à l'intention de l'ensemble des prestataires canadiens de soins de santé maternelle et de services en procréation, à l'ère des tests offerts dire
Keywords: هموفیلی B; Carrier screening; prenatal screening; autosomal recessive disorder; autosomal dominant disorder; X-linked disorder; thalassemia; hemoglobinopathy; cystic fibrosis; Duchenne/Becker muscular dystrophy; Fragile X; spinal muscular atrophy; Tay-Sachs disease;
Cost-Utility Analysis of Home-Based Care for Treatment of Thai Hemophilia A and B
Keywords: هموفیلی B; cost-utility; factor VIII concentrate; factor IX concentrate; hemophilia A; hemophilia B;
Efficient detection of factor IX mutations by denaturing high-performance liquid chromatography in Taiwanese hemophilia B patients, and the identification of two novel mutations
Keywords: هموفیلی B; Denaturing high-performance liquid chromatography (DHPLC); Factor IX (FIX); Hemophilia B
PROLONG-9FP clinical development program – phase I results of recombinant fusion protein linking coagulation factor IX with recombinant albumin (rIX-FP)
Keywords: هموفیلی B; Hemophilia B; Factor IX; Albumin fusion protein; Recombinant albumin; PROLONG-9FPAE, adverse event; AUC, area under the curve; cDNA, complementary DNA; FIX, factor IX; IR, incremental recovery; pdFIX, plasma-derived FIX; PK, pharmacokinetic; rFIX, recombi
Recalcitrant peroneal artery pseudoaneurysm in a patient with Hemophilia B
Keywords: هموفیلی B; Pseudoaneurysm; Hemophilia B; Coil embolization
Phase I/II, open-label, multicenter, safety, efficacy and PK study of a recombinant coagulation factor IX albumin fusion protein (rIX-FP) in subjects with hemophilia B
Keywords: هموفیلی B; Hemophilia B; Factor IX; Albumin fusion protein; Pharmacokinetics; Recombinant albumin; PROLONG-9FPAE, adverse event; AUC, area under the curve; EOS, end of study; FIX, factor IX; IR, incremental recovery; pdFIX, plasma-derived FIX; PK, pharmacokinetic; r
Innovative coagulation factors: albumin fusion technology and recombinant single-chain factor VIII
Keywords: هموفیلی B; Hemophilia B; Albumin fusion; Activated factor VII; Factor VIII; Factor IX; Half-lifeaPTT, activated partial thromboplastin time; FcRn, neonatal Fc receptor; FIX, factor IX; FVIIa, activated factor VII; FVIII, factor VIII; IgG, immunoglobulin G; PK, pharm
Global haemostasis assays, from bench to bedside
Keywords: هموفیلی B; α; angle that assesses rate of clot formation; α2M; α2-macroglobulin; AMC; 7-amino-4-methylcoumarine; AT; antithrombin; AUC; area under the curve; APC; activated protein C; aPTT; activated partial thromboplastin time; A10; the amplitude after ten minut
Human hepatoma cell line HuH-7 is an effective cellular system to produce recombinant factor IX with improved post-translational modifications
Keywords: هموفیلی B; Recombinant Factor IX (rFIX); Hemophilia B; HuH-7 cell line; Post-translational modifications (PTM); ESI–MS
Hemophilia management in transfusion medicine
Keywords: هموفیلی B; Hemophilia A; Hemophilia B; Coagulation factor concentrates (CFCs); Comprehensive care; Inhibitors; Prophylaxis
Labor and delivery in a patient with hemophilia B
Keywords: هموفیلی B; Hemophilia B; Labor and delivery; Coagulation; Cesarean section; General anesthesia; Thromboelastography
Emergency Department Care for Patients with Hemophilia and Von Willebrand Disease
Keywords: هموفیلی B; emergency care; hemophilia A; hemophilia B; replacement clotting factor; von Willebrand disease
Hemophilia B is a quasi-quantitative condition with certain mutations showing phenotypic plasticity
Keywords: هموفیلی B; Clotting activity; Continuous trait; Evolutionary conservation; Hemophilia B; Phenotypic plasticity; Prenatal diagnosis